Cardiovascular Disease Doctors in Chester, NJ Accepting Medicare

3 Cardiovascular Disease doctors found. Showing 1 - 3

Lawrence Charles Antonucci, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 415 Route 24, Suite E, Chester, NJ 07930 Phone: 908-879-1500    Fax: 908-879-1515

Clifford Sebastian, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 415 Route 24, Suite E, Chester, NJ 07930 Phone: 908-879-1500

Colleen M Coughlin, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 415 Rte 24 Ste 7, Chester, NJ 07930 Phone: 908-312-3770    Fax: 908-312-3771

News Archive

ProVation MD software chosen for cardiology procedure documentation at Creighton University Medical Center

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Creighton University Medical Center has selected ProVation® MD software for Cardiology procedure documentation and coding. The software will be used to document and code catheterization cases at The Cardiac Center of Creighton University.

Binge eating: Helping to stop binging while saving money

A new study finds that a self-guided, 12-week program helps binge eaters stop binging for up to a year and the program can also save money for those who participate. Recurrent binge eating is the most common eating disorder in the country, affecting more than three percent of the population, or nine million people, yet few treatment options are available.

FAO head highlights food security concerns, need for more agriculture investment

Rising oil prices and the recent drawdown in global cereal stocks could lead to a supply crisis and raise the risk of food riots in developing countries similar to those that occurred between 2007 and 2008, U.N. Food and Agriculture Organization Director General Jacques Diouf said in an interview with Reuters on Monday.

Acceleron Pharma and Shire announce joint development of ACE-031 for DMD

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, and Shire plc, the global specialty biopharmaceutical company, today announced a joint development and commercialization agreement for ACE-031 and other novel molecules targeting the activin receptor type IIB (ActRIIB) pathway. This pathway plays critical roles in regulating the growth of skeletal muscle.

Modified skin cells that may help protect cultured skin substitutes from infection

Cincinnati burn researchers have created genetically modified skin cells that, when added to cultured skin substitutes, may help fight off potentially lethal infections in patients with severe burns.

Read more Medical News

› Verified 2 days ago